Commonwealth Equity Services
FBIO icon

Commonwealth Equity Services’s Fortress Biotech FBIO Stock Holding History

Commonwealth Equity Services’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-61,527
Closed -$114K – 4296
2025
Q2 		$114K Buy
61,527
+30
+0% +$52 ﹤0.01% 4042
2025
Q1 		$96K Hold
61,497
– – ﹤0.01% 3999
2024
Q4 		$125K Hold
61,497
– – ﹤0.01% 3866
2024
Q3 		$89K Sell
61,497
-204
-0.3% -$388 ﹤0.01% 3883
2024
Q2 		$106K Sell
61,701
-16
-0% -$29 ﹤0.01% 3802
2024
Q1 		$123K Buy
61,717
+8,662
+16% +$17.2K ﹤0.01% 3761
2023
Q4 		$160K Buy
53,055
+50,857
+2,314% +$134K ﹤0.01% 3588
2023
Q3 		$10K Buy
2,198
+952
+76% +$6.53K ﹤0.01% 3776
2023
Q2 		$10K Buy
1,246
+292
+31% +$2.89K ﹤0.01% 3791
2023
Q1 		$11K Buy
954
+60
+7% +$714 ﹤0.01% 3717
2022
Q4 		$8K Hold
894
– – ﹤0.01% 3660
2022
Q3 		$11K Buy
894
+117
+15% +$1.75K ﹤0.01% 3615
2022
Q2 		$9K Buy
+777
New +$11.5K ﹤0.01% 3626

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Commonwealth Equity Services's FBIO Position: Q3 2025 in Review

Commonwealth Equity Services sold out of Fortress Biotech (FBIO) in Q3 2025, closing a stake of 61,527 shares — an estimated $114K sold.

Commonwealth Equity Services first reported a position in FBIO in Q2 2022 and held it in 13 quarters. The position peaked at $160K in Q4 2023. 56 funds tracked by Wall St. Rank hold FBIO as of Q3 2025.

  • Commonwealth Equity Services reported no remaining Fortress Biotech position as of Q3 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 61,527 Fortress Biotech shares in Q3 2025, an estimated $114K.
  • Commonwealth Equity Services first reported a position in Fortress Biotech in Q2 2022 and held it in 13 quarters.
  • Commonwealth Equity Services's Fortress Biotech position peaked at $160K in Q4 2023.
  • 56 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2025.

Based on Commonwealth Equity Services's 13F filing for Q3 2025, filed 22 Oct 2025.